New study: Pine bark reduces perimenopausa...( A study to be published in an upcomi...),Health

A study to be published in an upcoming edition of the Scandinavian Journal of Obstetrics and Gynaecology reveals that Pycnogenol (pic-noj-en-all), pine bark extract from the French maritime pine tree, reduces climacteric symptoms such as hot flashes, depression, panic attacks, cholesterol and other common symptoms associated with women entering menopause transition. The results suggest Pycnogenol may serve as an alternative treatment to estrogen replacement therapy, which is the most common remedy of pre-menopause (perimenopausal) symptoms.

According to the U.S. Department of Health and Human Services, perimenopause is the natural part of aging that signals the ending of a womans reproductive years. It marks the time when a womans body begins its move into menopause and can last anywhere from two to eight years.

Pycnogenol was chosen for this study due to previous research revealing health benefits associated with cognitive function, skin elasticity, nitric oxide stimulation, free radical scavenging and the broadening of antioxidant activity, said Dr. Peter Rohdewald, Institute of Pharmaceutical Chemistry at Germanys University of Munster and a lead researcher of this study. Achieving these health benefits is key to treating perimenopausal symptoms naturally.

The randomized, double-blind, placebo controlled study was conducted at Ham-Ming Hospital in Taiwan with 155 perimenopausal women. Each day, patients either received 200 mg Pycnogenol or placebo, and recorded their symptoms using the Womens Health Questionnaire (WHQ). The WHQ consisted of the following: somatic symptoms, depressed mood, vasomotoric symptoms, memory/concentration, attractiveness, anxiety, sexual behavior, sleep problems and menstrual symptoms.

Additionally, patients visited the clinic at one, three and six months following start of treatment. At each visit, BMI, blood pressure, lipid profile and total antioxidant status were recorded.